CLINICAL_TRIALS
trial_result
· 2019-08-14
Clinical Trial Update: Placebo-controlled RCT of Botulinum Toxin A as a Treatment for Provoked Vestibulodynia [Phase 3]
Summary
A phase 3, placebo-controlled trial evaluating Botulinum Toxin A for provoked vestibulodynia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Karolinska Institutet | Conditions: Vulvodynia | Phase 3 | Status: COMPLETED